RINVOQ- upadacitinib tablet, extended release
AbbVie Inc.
----------
MEDICATION GUIDE
RINVOQ® (RIN-VOKE) (upadacitinib) extended-release tablets, for oral use |
|||||||
What is the most important information I should know about RINVOQ?
RINVOQ can cause serious side effects, including: 1. Serious Infections. RINVOQ is a medicine that affects your immune system. RINVOQ can lower the ability of your immune system to fight infections. Some people have had serious infections while taking RINVOQ, including tuberculosis (TB), and infections caused by bacteria, fungi, or viruses that can spread throughout the body. Some people have died from these infections.
|
|||||||
|
|
|
|||||
After starting RINVOQ, call your healthcare provider right away if you have any symptoms of an infection. RINVOQ can make you more likely to get infections or make worse any infections that you have. If you get a serious infection, your healthcare provider may stop your treatment with RINVOQ until your infection is controlled. 2. Increased risk of death in people 50 years of age and older who have at least 1 heart disease (cardiovascular) risk factor and are taking a medicine in the class of medicines called Janus kinase (JAK) inhibitors. RINVOQ is a JAK inhibitor medicine. 3. Cancer and immune system problems. RINVOQ may increase your risk of certain cancers by changing the way your immune system works. Lymphoma and other cancers, including skin cancers can happen in people taking RINVOQ. People taking a medicine in the class of medicines called Janus kinase (JAK) inhibitors have a higher risk of certain cancers including lymphoma and lung cancer, especially if you are a current or past smoker. Tell your healthcare provider if you have ever had any type of cancer. Follow your healthcare provider’s advice about having your skin checked for skin cancer during treatment with RINVOQ. Limit the amount of time you spend in sunlight. Avoid using tanning beds or sunlamps. Wear protective clothing when you are in the sun and use a sunscreen with a high protection factor (SPF 30 and above). This is especially important if your skin is very fair or if you have a family history of skin cancer. 4. Increased risk of major cardiovascular events such as heart attack, stroke or death in people 50 years of age and older who have at least 1 heart disease (cardiovascular) risk factor and taking a medicine in the class of medicines called JAK inhibitors, especially if you are a current or past smoker. Get emergency help right away if you have any symptoms of a heart attack or stroke while taking RINVOQ, including:
Blood clots in the veins of your legs (deep vein thrombosis, DVT) or lungs (pulmonary embolism, PE) and arteries (arterial thrombosis) can happen in some people taking RINVOQ. This may be life-threatening and cause death. Blood clots in the veins of the legs (DVT) and lungs (PE) have happened more often in people who are 50 years of age and older and with at least 1 heart disease (cardiovascular) risk factor taking a medicine in the class of medicines called Janus kinase (JAK) inhibitors.
|
|||||||
○ swelling ○ pain or tenderness in one or both legs | ○ sudden unexplained chest or upper back pain ○ shortness of breath or difficulty breathing |
||||||
6. Allergic reactions. Symptoms such as rash (hives), trouble breathing, feeling faint or dizzy, or swelling of your lips, tongue, or throat, that may mean you are having an allergic reaction have been seen in people taking RINVOQ. Some of these reactions were serious. If any of these symptoms occur during treatment with RINVOQ, stop taking RINVOQ and get emergency medical help right away. |
|||||||
7. Tears (perforation) in the stomach or intestines.
|
|||||||
8. Changes in certain laboratory test results.
Your healthcare provider should do blood tests before you start taking RINVOQ and while you take RINVOQ to check for the following:
See “What are the possible side effects of RINVOQ?” for more information about side effects. |
|||||||
What is RINVOQ?
RINVOQ is a prescription medicine that is a Janus kinase (JAK) inhibitor. RINVOQ is used:
It is not known if RINVOQ is safe and effective in children with juvenile idiopathic arthritis, with psoriatic arthritis, with ankylosing spondylitis, or with non-radiographic axial spondyloarthritis. It is not known if RINVOQ is safe and effective in children under 12 years of age with atopic dermatitis. It is not known if RINVOQ is safe and effective in children with ulcerative colitis or with Crohn’s disease. |
|||||||
Do not take RINVOQ if you are allergic to upadacitinib or any of the ingredients in RINVOQ. See the end of this Medication Guide for a complete list of ingredients in RINVOQ. | |||||||
Before taking RINVOQ, tell your healthcare provider about all of your medical conditions, including if you:
|
|||||||
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. RINVOQ and other medicines may affect each other causing side effects. Especially tell your healthcare provider if you take:
Know the medicines you take. Keep a list of them to show your healthcare provider and pharmacist when you get a new medicine. |
|||||||
How should I take RINVOQ?
|
|||||||
What should I avoid while taking RINVOQ?
Avoid food or drink containing grapefruit during treatment with RINVOQ. Eating grapefruit or drinking grapefruit juice may increase the risk of side effects. |
|||||||
What are the possible side effects of RINVOQ?
RINVOQ may cause serious side effects, including:
|
|||||||
The most common side effects of RINVOQ in people treated for rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondyloarthritis include: | |||||||
• upper respiratory tract infections (common cold, sinus infections) • shingles (herpes zoster) • herpes simplex virus infections, including cold sores • bronchitis | • nausea • cough • fever • acne • headache |
||||||
The most common side effects of RINVOQ in people treated for atopic dermatitis include: | |||||||
• upper respiratory tract infections (common cold, sinus infections) • acne • herpes simplex virus infections, including cold sores • headache • increased blood levels of creatine phosphokinase • cough • allergic reactions • inflammation of hair follicles • nausea | • stomach-area (abdominal) pain • fever • increased weight • shingles (herpes zoster) • flu • tiredness • low white blood cell count (neutropenia) • muscle pain • flu-like illness |
||||||
The most common side effects of RINVOQ in people treated for ulcerative colitis include: | |||||||
• upper respiratory tract infections (common cold, sinus infections) • acne • herpes simplex virus infections, including cold sores • inflammation of the hair follicles • rash • flu | • shingles (herpes zoster) • increased blood cholesterol levels • increased blood levels of creatine phosphokinase • increased liver enzyme levels • low number of certain types of white blood cells (neutropenia, lymphopenia) |
||||||
The most common side effects of RINVOQ in people treated for Crohn’s disease include: | |||||||
• upper respiratory tract infections (common cold, sinus infections) • bronchitis • pneumonia • flu • acne • herpes simplex virus infections, including cold sores • tiredness • cough | • fever • shingles (herpes zoster) • headache • increased blood levels of creatine phosphokinase • increased liver enzyme levels • low number of red blood cells (anemia) • low number of white blood cells (neutropenia, leukopenia) • infection of the stomach and intestine (gastroenteritis) |
||||||
Separation or tear to the lining of the back part of the eye (retinal detachment) has happened in people with atopic dermatitis treated with RINVOQ. Call your healthcare provider right away if you have any sudden changes in your vision during treatment with RINVOQ. Some people taking RINVOQ may see medicine residue (a whole tablet or tablet pieces) in their stool. If this happens, call your healthcare provider. These are not all the possible side effects of RINVOQ. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088. |
|||||||
How should I store RINVOQ?
|
|||||||
General information about the safe and effective use of RINVOQ.
Medicines are sometimes prescribed for purposes other than those listed in a Medication Guide. Do not use RINVOQ for a condition for which it was not prescribed. Do not give RINVOQ to other people, even if they have the same symptoms that you have. It may harm them. You can ask your pharmacist or healthcare provider for information about RINVOQ that is written for health professionals. |
|||||||
What are the ingredients in RINVOQ 15 mg tablets?
Active ingredient: upadacitinib Inactive ingredients: colloidal silicon dioxide, ferrosoferric oxide, hypromellose, iron oxide red, magnesium stearate, mannitol, microcrystalline cellulose, polyvinyl alcohol, polyethylene glycol, talc, tartaric acid and titanium dioxide. What are the ingredients in RINVOQ 30 mg tablets? Active ingredient: upadacitinib Inactive ingredients: colloidal silicon dioxide, hypromellose, iron oxide red, magnesium stearate, mannitol, microcrystalline cellulose, polyvinyl alcohol, polyethylene glycol, talc, tartaric acid and titanium dioxide. What are the ingredients in RINVOQ 45 mg tablets? Active ingredient: upadacitinib Inactive ingredients: colloidal silicon dioxide, hypromellose, iron oxide yellow and iron oxide red, magnesium stearate, mannitol, microcrystalline cellulose, polyvinyl alcohol, polyethylene glycol, talc, tartaric acid and titanium dioxide. Manufactured by: AbbVie Inc., North Chicago, IL 60064, USA RINVOQ® is a registered trademark of AbbVie Biotechnology Ltd. ©2019-2023 AbbVie Inc. For more information, call 1-800 2-RINVOQ (1-800-274-6867) or go to www.RINVOQ.com. |
|||||||
This Medication Guide has been approved by the U.S. Food and Drug Administration 20080240 | Revised: 11/2023 |